Last updated: 2026-10-12 21:09:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $264.08, with a market capitalization of $630.04B and a P/E ratio of 29.95. Over the past 52 weeks, its price has ranged from $184.66 to $281.07. This page covers its latest market performance, valuation, price trends and company information.
$630.04B | |
$261.60 | |
$281.07 | |
$46.25 | |
$261.44 | |
4.34M | |
7.03M | |
29.95 | |
$281.07 | |
$184.66 | |
2.00% | |
-- |
Johnson & Johnson (JNJ) is trading at $264.40 in after-hours trading as of 2026-10-12 21:07:00, up 1.13% ($2.96) from the regular-session close of $261.44.
After-hours trading shows how investors are pricing JNJ after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Johnson & Johnson (JNJ) moved from $258.66 to $264.08, representing a gain of 2.09% ($5.42).
The stock traded between $251.17 and $264.31 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 7.46 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 82.4%
JNJ is currently trading at $264.08, placing it 82.4% of the way from its 52-week low of $184.66 to its 52-week high of $281.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.